Literature DB >> 21900567

Vulnerability to depression: from brain neuroplasticity to identification of biomarkers.

Aurélie Blugeot1, Cyril Rivat, Elodie Bouvier, Jenny Molet, Amandine Mouchard, Brigitte Zeau, Christophe Bernard, Jean-Jacques Benoliel, Chrystel Becker.   

Abstract

A stressful event increases the risk of developing depression later in life, but the possible predisposing factors remain unknown. Our study aims to characterize latent vulnerability traits underlying the development of depressive disorders in adult animals. Four weeks after a priming stressful event, serum corticosterone concentration returned to control values in all animals, whereas the other biological parameters returned to basal level in only 58% of animals (called nonvulnerable). In contrast, 42% of animals displayed persistent decreased serum and hippocampus BDNF concentrations, reduced hippocampal volume and neurogenesis, CA3 dendritic retraction and decrease in spine density, as well as amygdala neuron hypertrophy, constituting latent vulnerability traits to depression. In this group, called vulnerable, a subsequent mild stress evoked a rise of serum corticosterone levels and a "depressive" phenotype, in contrast to nonvulnerable animals. Intracerebroventricular administration of 7,8-dihydroxyflavone, a selective TrkB receptor agonist, dampened the development of the "depressive" phenotype. Our results thus characterize the presence of latent vulnerability traits that underlie the emergence of depression and identify the association of low BDNF with normal corticosterone serum concentrations as a predictive biomarker of vulnerability to depression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21900567      PMCID: PMC6623387          DOI: 10.1523/JNEUROSCI.1309-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  71 in total

Review 1.  Preclinical studies modeling deep brain stimulation for depression.

Authors:  Clement Hamani; José N Nobrega
Journal:  Biol Psychiatry       Date:  2012-06-29       Impact factor: 13.382

2.  Primed for Problems: Stress Confers Vulnerability to Epilepsy and Associated Comorbidities.

Authors:  Jamie Maguire
Journal:  Epilepsy Curr       Date:  2015 Nov-Dec       Impact factor: 7.500

3.  Glucocorticoid receptor deletion from the dorsal raphé nucleus of mice reduces dysphoria-like behavior and impairs hypothalamic-pituitary-adrenocortical axis feedback inhibition.

Authors:  Melanie Y Vincent; Lauren Jacobson
Journal:  Eur J Neurosci       Date:  2014-03-29       Impact factor: 3.386

Review 4.  Fear extinction and BDNF: translating animal models of PTSD to the clinic.

Authors:  R Andero; K J Ressler
Journal:  Genes Brain Behav       Date:  2012-05-11       Impact factor: 3.449

5.  Building health behavior models to guide the development of just-in-time adaptive interventions: A pragmatic framework.

Authors:  Inbal Nahum-Shani; Eric B Hekler; Donna Spruijt-Metz
Journal:  Health Psychol       Date:  2015-12       Impact factor: 4.267

Review 6.  Epigenetic mechanisms underlying the role of brain-derived neurotrophic factor in depression and response to antidepressants.

Authors:  Florian Duclot; Mohamed Kabbaj
Journal:  J Exp Biol       Date:  2015-01-01       Impact factor: 3.312

7.  Brain neuroplastic changes accompany anxiety and memory deficits in a model of complex regional pain syndrome.

Authors:  Maral Tajerian; David Leu; Yani Zou; Peyman Sahbaie; Wenwu Li; Hamda Khan; Vivian Hsu; Wade Kingery; Ting Ting Huang; Lino Becerra; J David Clark
Journal:  Anesthesiology       Date:  2014-10       Impact factor: 7.892

8.  Small-molecule trkB agonists promote axon regeneration in cut peripheral nerves.

Authors:  Arthur W English; Kevin Liu; Jennifer M Nicolini; Amanda M Mulligan; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 9.  The Diathesis-Epilepsy Model: How Past Events Impact the Development of Epilepsy and Comorbidities.

Authors:  Christophe Bernard
Journal:  Cold Spring Harb Perspect Med       Date:  2016-06-01       Impact factor: 6.915

10.  Hemodialysis decreases serum brain-derived neurotrophic factor concentration in humans.

Authors:  Jerzy A Zoladz; Michał Śmigielski; Joanna Majerczak; Łukasz R Nowak; Justyna Zapart-Bukowska; Olgierd Smoleński; Jan Kulpa; Krzysztof Duda; Joanna Drzewińska; Grzegorz Bartosz
Journal:  Neurochem Res       Date:  2012-08-19       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.